Results 81 to 90 of about 792 (133)
Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial. [PDF]
REC Interv CardiolBernal-Labrador E, Romaguera R, García-Blas S, Regueiro A, Serra V, Asmarats L, Tizón-Marcos H, Agudelo V, Scardino C, Casanova-Sandoval JM, Rodríguez-Gabella T, Jiménez-Méndez C, Pérez-Rivera Á, Robles-Gamboa C, Ayesta A, Díez-Villanueva P, Raposeiras-Roubín S, Amat-Santos IJ, Esteve-Pastor A, Veiga-Fernández G, Anguita M, Martí-Sánchez D, Martínez-Velilla N, Cortés L, Calvo E, Asimbaya S, Formiga F, Ariza-Solé A. +27 moreeuropepmc +1 more sourceAnifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. [PDF]
RMD OpenCalvo-Río V, Secada-Gómez C, Martín-Gutiérrez A, Retuerto-Guerrero M, Font J, Casafont-Solé I, Mayo-Juanatey A, Alegre Sancho JJ, Freites D, Hormigos C, Garrido Puñal N, González Arribas G, Miguélez Sanchez JR, García-Valle A, Ibañez M, Lozano Morillo F, García Manzanares Á, Sandoval-Moreno S, Cortes-Hernandez J, Palma Sanchez D, Lojo L, Cervantes Pérez EC, Collado P, Arciniega Larios C, Sala Icardo L, Labrador-Sánchez E, Peralta-Ginés C, Urionagüena Onaindia I, Plaza-Aulestia N, Medina Malone M, Gómez de Salazar JR, Corteguera M, Cebrián-Méndez L, Antón Pages FA, Lamua Riazuelo JR, Fábregas Canales MD, Alados Hernández MJ, Garijo Bufort M, Pàmies A, Sarabia de Ardanaz L, Aguirre-Del-Pino R, Cabezas Lefler JÁ, Seijas-Lopez Á, Carrasco Cubero MDC, López-Cerón Cofiño A, Ortiz-Santamaria V, Laiño Piñeiro M, Ordás Calvo C, Arconada Lopez C, Urruticoechea-Arana A, Garcia Magallon B, Acosta Alfaro AV, Leal Rodriguez S, Salido Olivares M, Lavilla Villar P, Brandy-García AM, Ros Vilamajo I, García Martos Á, Magallares Lopez BP, Sada Urmeneta G, Córdoba Martín C, Riera E, Bejerano C, Castañeda S, Blanco R. +64 moreeuropepmc +1 more sourceImmunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes. [PDF]
Pneumonia (Nathan)Galli F, Forin E, Motos A, Molina Saldarriaga FJ, Gabarrus A, Canseco J, Fernandez-Barat L, Barbeta E, Calabretta D, Ceccato A, Bermejo-Martin JF, Ferrer R, Riera J, Penuelas O, Lorente JA, de Gonzalo-Calvo D, Menendez R, Gonzalez J, Palomeque A, Soler-Comas A, Amaya-Villar R, Anon JM, Marino AB, Barbera C, Barberan J, Ortiz AB, Bustamante-Munguira E, Caballero J, Canton-Bulnes ML, Perez CC, Carbonell N, Catalan-Gonzalez M, de Frutos R, Franco N, Galban C, Lago AL, Gumucio-Sanguino VD, Del Carmen de la Torre M, Diaz E, Estella A, Gallego Curto E, Garcia-Garmendia JL, Gomez JM, Huerta A, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J, Martin Delgado MC, Martinez de la Gandara A, Martinez Varela I, Lopez Messa J, Albaiceta GM, Nieto MT, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC, Ricart P, Sagredo V, Sanchez-Miralles A, Sancho Chinesta S, Roche-Campo F, Socias L, Sole-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A, Valdivia LJ, Vidal P, Boado MV, Rodriguez A, Ferrer M, Barbe F, Torres A, CIBERESUCICOVID Project investigators (COV20/00110, ISCIII). +76 moreeuropepmc +1 more source